Global Fibrin Glue Market Size, Share, Development, Growth and Demand Forecast to 2023 - Research and Markets

DUBLIN--()--The "Global Fibrin Glue Market Size, Share, Development, Growth and Demand Forecast to 2023" report has been added to Research and Markets' offering.

Market Dynamics

The global fibrin glue market is expected to witness a CAGR of 10.9% during the period, 2017 - 2023.

Rising healthcare expenditure, increasing number of surgical procedures and burn cases are some of the key factors, driving the growth of the global fibrin glue market growth.

Additionally, increasing prevalence of chronic diseases, aging population, low chances of complications associated with these products and increase in road accidents also support the growth of the global market.

Opportunities

Improved healthcare in the emerging economies provides immense growth opportunities for the global fibrin glue market.

The overall healthcare industry is undergoing rapid changes in the emerging economies due to rising government expenditure, increasing number of hospitals, increase in the number of surgeries, and rising healthcare awareness. Emerging economies provide suitable opportunities for the growth of the global fibrin glue market.

Growth Drivers

Rising healthcare expenditure is one of the key drivers of the fibrin glue market. According to Centers for Disease Control and Prevention (CDC), total national health expenditure in the U.S. stood at $3.0 trillion in 2014 and per capita national health expenditure was $9,523.

As per the reports of the U.K. Office for National Statistics (ONS), the U.K.'s total healthcare expenditure was $297.8 billion, in 2014.

Key Topics Covered:

1. Research Background

2. Research Methodology

3. Executive Summary

4. Introduction

5. Market Size And Forecast By Application

6. Market Size And Forecast By Geography

7. Competitive Landscape

8. Company Profiles

  • Vivostat A/S
  • Kaketsuken
  • Johnson & Johnson
  • Baxter International Inc.
  • Csl Behring
  • Zimmer Biomet Holdings, Inc.
  • Takeda Pharmaceutical Company Limited
  • Shanghai Raas Blood Products Co. Ltd
  • Hualan Biological Engineering Inc.
  • Mallinckrodt Plc

9. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/bsjscc/global_fibrin

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Hematological Drugs, Adhesives and Sealants

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Hematological Drugs, Adhesives and Sealants